Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
This grant funds early-stage innovative technology development aimed at advancing basic and clinical cancer research.
About this program
The Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research grant supports projects that focus on the development of innovative technologies to improve cancer research. This grant is intended for researchers and organizations engaged in cancer research, particularly those working on early-stage technologies that can lead to significant advancements in the field. The funding aims to facilitate the transition of innovative ideas from the laboratory to practical applications in cancer treatment and prevention. Eligible applicants include academic institutions, nonprofit organizations, and small businesses that are involved in cancer research. The grant encourages collaboration among researchers, clinicians, and technology developers to foster innovation and accelerate the development of new tools and methodologies in cancer research. By providing financial support, this grant aims to enhance the capabilities of researchers to explore novel approaches and technologies that can ultimately benefit cancer patients.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and small businesses involved in cancer research.